Patient info

Dubam cream – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: General sale (GSL) Details

Medicine strength:
200 mg/gram + 20 mg/gram + 10 mg/gram
Contains active substances:

Summary of Product Characteristics (SmPC) - Dubam cream

SUMMARY OF PRODUCT CHARACTERISTICS

1 NAME OF THE MEDICINAL PRODUCT

2.   QUALITATIVE AND QUANTITATIVE COMPOSITION

3 PHARMACEUTICAL FORM

Cream

A smooth white to off-white cream

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

External application for the symptomatic relief of muscle stiffness, muscular rheumatism, lumbago, sciatica, fibrositis, sprains and chilblains.

4.2. Posology and method of administration

Apply externally with gentle massage two to three times a day avoiding broken or inflamed skin.

Do not apply to children under six years old.

4.3. Contra-indications

Known sensitivity to any of the actives.

Do not apply to children under six years old.

4.4. Special warnings and precautions for use

Do not apply to broken or inflamed skin.

Application on mucous membranes should be avoided.

Discontinue if rash develops.

Not for use with occlusive dressings.

Topical application may result in systemic effects, including asthma.

Patients should be advised against excessive exposure of areas treated to sunlight, in order to avoid possibility of photosensitivity.

For external use only. Keep away from eyes. Wash hands after use

4.5. Interactions with other medicinal products and other forms of interaction

None known.

4.6. Pregnancy and lactation

As with most medicines, use in pregnancy or breastfeeding should be avoided.

4.7. Effects on ability to drive and use machines

Not applicable.

4.8 Undesirable effects

As with all topical medicines, photosensitivity and application site reactions may occur.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard

4.9. Overdose

4.9. Overdose

Not applicable.

PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

All the active ingredients in Dubam Cream are topical vasodilators and their effect is rubifacient.

5.2. Pharmacokinetic properties

External application of Dubam Cream to intact skin results in negligible systemic absorption.

5.3. Preclinical safety data

5.3. Preclinical safety data

Not applicable.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Emulsifying Wax, Liquid Paraffin, Polysorbate 80, Purified Water.

6.2. Incompatibilities

None known

6.3. Shelf life

36 Months.

6.4. Special precautions for storage

Store between 4°C and 25°C.

6.5. Nature and contents of container

6.5. Nature and contents of container

30g Aluminium Tube

6.6. Instruction for use/handling

No special handling is required.

7 MARKETING AUTHORISATION HOLDER

Norma Chemicals Ltd.

51–53 Stert Street

Abingdon

Oxfordshire OX14 3JF

United Kingdom

8. MARKETING AUTHORISATION NUMBER

PL 00386/5015R

9. DATE OF FIRST AUTHORISATION/RE­NEWAL OF

AUTHORISATION

29 December 1083 / 28 February 1995

Facts about Dubam cream

Prescription needed? No, general sale list medicine (GSL) – also sold outside pharmacies
Active substances Cineole, Methyl salicylate, Menthol
Strength 200 mg/gram + 20 mg/gram + 10 mg/gram
Pharmaceutical form Cutaneous cream
How is it taken Cutaneous
Pack sizes 30 gram
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Marketing authorisation PL 00386/5015
Codes GTIN 5060676350026 · BNF 10030200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.3.0 of 26 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.